Human Genome, Glaxo Lupus Drug Moves Forward

Human Genome and GlaxoSmithKline will seek FDA approval in the first half of next year for Lupus drug Benlista. CNBC's Mike Huckman discusses the drug with Thomas Watkins, of Human Genome Sciences. (CNBC)

MSNBC | November 2, 2009

Tags:. .glaxo. .glaxosmithkline. .huckman. .cnbc. .lupus